vs
Fathom Holdings Inc.（FTHM）与PUMA BIOTECHNOLOGY, INC.（PBYI）财务数据对比。点击上方公司名可切换其他公司
Fathom Holdings Inc.的季度营收约是PUMA BIOTECHNOLOGY, INC.的1.2倍（$90.6M vs $75.5M），PUMA BIOTECHNOLOGY, INC.同比增速更快（27.7% vs -1.2%），PUMA BIOTECHNOLOGY, INC.自由现金流更多（$14.4M vs $-20.7M），过去两年PUMA BIOTECHNOLOGY, INC.的营收复合增速更高（31.3% vs 13.4%）
Fathom Holdings Inc.是一家总部位于美国的房地产科技与服务企业，为房产经纪人、经纪机构和消费者提供数字交易管理、按揭服务、产权保险、住宅经纪等一站式解决方案，业务覆盖美国大部分区域市场。
彪马生物技术是一家公开上市的生物制药企业，总部位于美国加利福尼亚州洛杉矶，专注于创新药物研发相关业务，在生物制药领域开展研发与商业化运营。
FTHM vs PBYI — 直观对比
营收规模更大
FTHM
是对方的1.2倍
$75.5M
营收增速更快
PBYI
高出29.0%
-1.2%
自由现金流更多
PBYI
多$35.0M
$-20.7M
两年增速更快
PBYI
近两年复合增速
13.4%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $90.6M | $75.5M |
| 净利润 | $-6.7M | — |
| 毛利率 | — | 69.3% |
| 营业利润率 | -5.2% | 22.7% |
| 净利率 | -7.4% | — |
| 营收同比 | -1.2% | 27.7% |
| 净利润同比 | -7.7% | — |
| 每股收益（稀释后） | $-0.20 | $0.26 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收FTHMPBYI
| Q4 25 | $90.6M | $75.5M | ||
| Q3 25 | $115.3M | $54.5M | ||
| Q2 25 | $121.4M | $52.4M | ||
| Q1 25 | $93.1M | $46.0M | ||
| Q4 24 | $91.7M | $59.1M | ||
| Q3 24 | $83.7M | $80.5M | ||
| Q2 24 | $89.2M | $47.1M | ||
| Q1 24 | $70.5M | $43.8M |
净利润FTHMPBYI
| Q4 25 | $-6.7M | — | ||
| Q3 25 | $-4.4M | $8.8M | ||
| Q2 25 | $-3.6M | $5.9M | ||
| Q1 25 | $-5.6M | $3.0M | ||
| Q4 24 | $-6.2M | — | ||
| Q3 24 | $-8.1M | $20.3M | ||
| Q2 24 | $-1.3M | $-4.5M | ||
| Q1 24 | $-5.9M | $-4.8M |
毛利率FTHMPBYI
| Q4 25 | — | 69.3% | ||
| Q3 25 | — | 77.7% | ||
| Q2 25 | — | 76.5% | ||
| Q1 25 | — | 77.1% | ||
| Q4 24 | — | 76.4% | ||
| Q3 24 | — | 63.9% | ||
| Q2 24 | — | 77.4% | ||
| Q1 24 | — | 75.5% |
营业利润率FTHMPBYI
| Q4 25 | -5.2% | 22.7% | ||
| Q3 25 | -3.5% | 17.6% | ||
| Q2 25 | -2.0% | 12.7% | ||
| Q1 25 | -4.8% | 8.7% | ||
| Q4 24 | -7.0% | 22.6% | ||
| Q3 24 | -9.3% | 27.4% | ||
| Q2 24 | -4.1% | -4.6% | ||
| Q1 24 | -8.0% | -5.3% |
净利率FTHMPBYI
| Q4 25 | -7.4% | — | ||
| Q3 25 | -3.8% | 16.2% | ||
| Q2 25 | -3.0% | 11.2% | ||
| Q1 25 | -6.1% | 6.5% | ||
| Q4 24 | -6.8% | — | ||
| Q3 24 | -9.7% | 25.2% | ||
| Q2 24 | -1.5% | -9.6% | ||
| Q1 24 | -8.4% | -11.0% |
每股收益（稀释后）FTHMPBYI
| Q4 25 | $-0.20 | $0.26 | ||
| Q3 25 | $-0.15 | $0.17 | ||
| Q2 25 | $-0.13 | $0.12 | ||
| Q1 25 | $-0.24 | $0.06 | ||
| Q4 24 | $-0.29 | $0.40 | ||
| Q3 24 | $-0.40 | $0.41 | ||
| Q2 24 | $-0.07 | $-0.09 | ||
| Q1 24 | $-0.31 | $-0.10 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $5.8M | $97.5M |
| 总债务越低越好 | $5.6M | $22.7M |
| 股东权益账面价值 | $37.4M | $130.3M |
| 总资产 | $78.0M | $216.3M |
| 负债/权益比越低杠杆越低 | 0.15× | 0.17× |
8季度趋势，按日历期对齐
现金及短期投资FTHMPBYI
| Q4 25 | $5.8M | $97.5M | ||
| Q3 25 | $9.8M | $94.4M | ||
| Q2 25 | $4.9M | $96.0M | ||
| Q1 25 | $8.0M | $93.2M | ||
| Q4 24 | $7.1M | $101.0M | ||
| Q3 24 | $13.1M | $96.7M | ||
| Q2 24 | $10.4M | $96.8M | ||
| Q1 24 | $5.7M | $107.2M |
总债务FTHMPBYI
| Q4 25 | $5.6M | $22.7M | ||
| Q3 25 | $5.1M | $34.0M | ||
| Q2 25 | $5.1M | $45.3M | ||
| Q1 25 | $5.1M | $56.7M | ||
| Q4 24 | $9.5M | $68.0M | ||
| Q3 24 | $8.8M | $79.3M | ||
| Q2 24 | $3.6M | $90.7M | ||
| Q1 24 | $3.7M | $102.0M |
股东权益FTHMPBYI
| Q4 25 | $37.4M | $130.3M | ||
| Q3 25 | $43.4M | $115.3M | ||
| Q2 25 | $40.7M | $104.7M | ||
| Q1 25 | $43.4M | $97.1M | ||
| Q4 24 | $44.7M | $92.1M | ||
| Q3 24 | $47.1M | $71.1M | ||
| Q2 24 | $53.1M | $48.5M | ||
| Q1 24 | $51.9M | $51.0M |
总资产FTHMPBYI
| Q4 25 | $78.0M | $216.3M | ||
| Q3 25 | $83.2M | $202.9M | ||
| Q2 25 | $80.4M | $194.9M | ||
| Q1 25 | $81.0M | $196.2M | ||
| Q4 24 | $75.4M | $213.3M | ||
| Q3 24 | $80.9M | $220.7M | ||
| Q2 24 | $80.2M | $205.0M | ||
| Q1 24 | $78.2M | $214.1M |
负债/权益比FTHMPBYI
| Q4 25 | 0.15× | 0.17× | ||
| Q3 25 | 0.12× | 0.30× | ||
| Q2 25 | 0.12× | 0.43× | ||
| Q1 25 | 0.12× | 0.58× | ||
| Q4 24 | 0.21× | 0.74× | ||
| Q3 24 | 0.19× | 1.12× | ||
| Q2 24 | 0.07× | 1.87× | ||
| Q1 24 | 0.07× | 2.00× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-20.5M | $14.4M |
| 自由现金流经营现金流 - 资本支出 | $-20.7M | $14.4M |
| 自由现金流率自由现金流/营收 | -22.8% | 19.1% |
| 资本支出强度资本支出/营收 | 0.1% | 0.0% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-29.4M | $41.7M |
8季度趋势，按日历期对齐
经营现金流FTHMPBYI
| Q4 25 | $-20.5M | $14.4M | ||
| Q3 25 | $3.0M | $9.7M | ||
| Q2 25 | $-5.9M | $14.1M | ||
| Q1 25 | $-5.7M | $3.6M | ||
| Q4 24 | $-4.7M | $15.6M | ||
| Q3 24 | $-330.0K | $11.0M | ||
| Q2 24 | $-3.1M | $1.0M | ||
| Q1 24 | $-947.0K | $11.2M |
自由现金流FTHMPBYI
| Q4 25 | $-20.7M | $14.4M | ||
| Q3 25 | $3.0M | $9.7M | ||
| Q2 25 | $-6.0M | $14.1M | ||
| Q1 25 | $-5.8M | $3.6M | ||
| Q4 24 | $-4.7M | $15.6M | ||
| Q3 24 | $-364.0K | $11.0M | ||
| Q2 24 | $-3.1M | $1.0M | ||
| Q1 24 | $-948.0K | — |
自由现金流率FTHMPBYI
| Q4 25 | -22.8% | 19.1% | ||
| Q3 25 | 2.6% | 17.7% | ||
| Q2 25 | -4.9% | 26.8% | ||
| Q1 25 | -6.2% | 7.7% | ||
| Q4 24 | -5.2% | 26.4% | ||
| Q3 24 | -0.4% | 13.7% | ||
| Q2 24 | -3.5% | 2.1% | ||
| Q1 24 | -1.3% | — |
资本支出强度FTHMPBYI
| Q4 25 | 0.1% | 0.0% | ||
| Q3 25 | 0.0% | 0.0% | ||
| Q2 25 | 0.0% | 0.0% | ||
| Q1 25 | 0.0% | 0.1% | ||
| Q4 24 | 0.1% | 0.0% | ||
| Q3 24 | 0.0% | 0.0% | ||
| Q2 24 | 0.0% | 0.0% | ||
| Q1 24 | 0.0% | 0.0% |
现金转化率FTHMPBYI
| Q4 25 | — | — | ||
| Q3 25 | — | 1.10× | ||
| Q2 25 | — | 2.41× | ||
| Q1 25 | — | 1.21× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 0.54× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
FTHM
| Real Estate Brokerage | $84.9M | 94% |
| Mortgage Segment | $3.4M | 4% |
| Other | $2.3M | 3% |
PBYI
暂无分部数据
